Connection

Christopher Mcmahan to Humans

Back to Details
This is a "connection" page, showing publications Christopher Mcmahan has written about Humans.
Christopher Mcmahan
Connection Strength
0.601
Humans
  1. Predicting nicotine metabolism across ancestries using genotypes. BMC Genomics. 2022 Sep 21; 23(1):663.
    View in: PubMed
    Score: 0.032
  2. Assessing Opioid Use Disorder Treatments in Trials Subject to Non-Adherence via a Functional Generalized Linear Mixed-Effects Model. Int J Environ Res Public Health. 2022 04 29; 19(9).
    View in: PubMed
    Score: 0.031
  3. Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in a University Student Population. Clin Infect Dis. 2022 03 01; 74(4):719-722.
    View in: PubMed
    Score: 0.031
  4. A Bayesian mixed effects support vector machine for learning and predicting daily substance use disorder patterns. Am J Drug Alcohol Abuse. 2022 Jul 04; 48(4):413-421.
    View in: PubMed
    Score: 0.031
  5. COVID-19 wastewater epidemiology: a model to estimate infected populations. Lancet Planet Health. 2021 12; 5(12):e874-e881.
    View in: PubMed
    Score: 0.030
  6. Informative array testing with multiplex assays. Stat Med. 2021 06 15; 40(13):3021-3034.
    View in: PubMed
    Score: 0.029
  7. Modelling the impact of presemester testing on COVID-19 outbreaks in university campuses. BMJ Open. 2020 12 15; 10(12):e042578.
    View in: PubMed
    Score: 0.028
  8. The objective function controversy for group testing: Much ado about nothing? Stat Med. 2019 10 30; 38(24):4912-4923.
    View in: PubMed
    Score: 0.026
  9. Informative group testing for multiplex assays. Biometrics. 2019 03; 75(1):278-288.
    View in: PubMed
    Score: 0.025
  10. Adaptive elastic net for group testing. Biometrics. 2019 03; 75(1):13-23.
    View in: PubMed
    Score: 0.025
  11. A partially linear proportional hazards model for current status data. Biometrics. 2018 12; 74(4):1240-1249.
    View in: PubMed
    Score: 0.024
  12. Hierarchical group testing for multiple infections. Biometrics. 2017 06; 73(2):656-665.
    View in: PubMed
    Score: 0.021
  13. Rejoinder to "Reader reaction: A note on the evaluation of group testing algorithms in the presence of misclassification". Biometrics. 2016 Mar; 72(1):303-4.
    View in: PubMed
    Score: 0.020
  14. Regression analysis for current status data using the EM algorithm. Stat Med. 2013 Nov 10; 32(25):4452-66.
    View in: PubMed
    Score: 0.017
  15. Regression models for group testing data with pool dilution effects. Biostatistics. 2013 Apr; 14(2):284-98.
    View in: PubMed
    Score: 0.016
  16. Two-dimensional informative array testing. Biometrics. 2012 Sep; 68(3):793-804.
    View in: PubMed
    Score: 0.015
  17. Informative Dorfman screening. Biometrics. 2012 Mar; 68(1):287-96.
    View in: PubMed
    Score: 0.015
  18. A flexible parametric approach for analyzing arbitrarily censored data that are potentially subject to left truncation under the proportional hazards model. Lifetime Data Anal. 2023 01; 29(1):188-212.
    View in: PubMed
    Score: 0.008
  19. Capturing the pool dilution effect in group testing regression: A Bayesian approach. Stat Med. 2022 10 15; 41(23):4682-4696.
    View in: PubMed
    Score: 0.008
  20. Effectiveness and protection duration of Covid-19 vaccines and previous infection against any SARS-CoV-2 infection in young adults. Nat Commun. 2022 07 08; 13(1):3946.
    View in: PubMed
    Score: 0.008
  21. Effects of Buprenorphine Dose and Therapeutic Engagement on Illicit Opiate Use in Opioid Use Disorder Treatment Trials. Int J Environ Res Public Health. 2022 03 30; 19(7).
    View in: PubMed
    Score: 0.008
  22. Multiethnic Prediction of Nicotine Biomarkers and Association With Nicotine Dependence. Nicotine Tob Res. 2021 11 05; 23(12):2162-2169.
    View in: PubMed
    Score: 0.008
  23. Global estimated Disability-Adjusted Life-Years (DALYs) of diarrheal diseases: A systematic analysis of data from 28 years of the global burden of disease study. PLoS One. 2021; 16(10):e0259077.
    View in: PubMed
    Score: 0.008
  24. Generalized additive regression for group testing data. Biostatistics. 2021 10 13; 22(4):873-889.
    View in: PubMed
    Score: 0.008
  25. The impact of phased university reopenings on mitigating the spread of COVID-19: a modeling study. BMC Public Health. 2021 08 06; 21(1):1520.
    View in: PubMed
    Score: 0.007
  26. Genetic risk factors for colorectal cancer in multiethnic Indonesians. Sci Rep. 2021 05 11; 11(1):9988.
    View in: PubMed
    Score: 0.007
  27. Surveillance-based informative testing for detection and containment of SARS-CoV-2 outbreaks on a public university campus: an observational and modelling study. Lancet Child Adolesc Health. 2021 06; 5(6):428-436.
    View in: PubMed
    Score: 0.007
  28. Incorporating the dilution effect in group testing regression. Stat Med. 2021 05 20; 40(11):2540-2555.
    View in: PubMed
    Score: 0.007
  29. Array testing for multiplex assays. Biostatistics. 2020 07 01; 21(3):417-431.
    View in: PubMed
    Score: 0.007
  30. Local and regional temporal trends (2013-2019) of canine Ehrlichia spp. seroprevalence in the USA. Parasit Vectors. 2020 Mar 30; 13(1):153.
    View in: PubMed
    Score: 0.007
  31. From mixed effects modeling to spike and slab variable selection: A Bayesian regression model for group testing data. Biometrics. 2020 09; 76(3):913-923.
    View in: PubMed
    Score: 0.007
  32. Canine vector-borne disease: mapping and the accuracy of forecasting using big data from the veterinary community. Anim Health Res Rev. 2019 06; 20(1):47-60.
    View in: PubMed
    Score: 0.007
  33. A two-phase Bayesian methodology for the analysis of binary phenotypes in genome-wide association studies. Biom J. 2020 01; 62(1):191-201.
    View in: PubMed
    Score: 0.007
  34. Quantifying the relationship between human Lyme disease and Borrelia burgdorferi exposure in domestic dogs. Geospat Health. 2019 05 14; 14(1).
    View in: PubMed
    Score: 0.006
  35. An extended proportional hazards model for interval-censored data subject to instantaneous failures. Lifetime Data Anal. 2020 01; 26(1):158-182.
    View in: PubMed
    Score: 0.006
  36. Study design with staggered sampling times for evaluating sustained unresponsiveness to peanut sublingual immunotherapy. Stat Med. 2018 11 30; 37(27):3944-3958.
    View in: PubMed
    Score: 0.006
  37. Biosignature Discovery for Substance Use Disorders Using Statistical Learning. Trends Mol Med. 2018 02; 24(2):221-235.
    View in: PubMed
    Score: 0.006
  38. Group testing regression models with dilution submodels. Stat Med. 2017 Dec 30; 36(30):4860-4872.
    View in: PubMed
    Score: 0.006
  39. Bayesian regression for group testing data. Biometrics. 2017 12; 73(4):1443-1452.
    View in: PubMed
    Score: 0.006
  40. A general framework for the regression analysis of pooled biomarker assessments. Stat Med. 2017 07 10; 36(15):2363-2377.
    View in: PubMed
    Score: 0.006
  41. Estimating the prevalence of multiple diseases from two-stage hierarchical pooling. Stat Med. 2016 09 20; 35(21):3851-64.
    View in: PubMed
    Score: 0.005
  42. Estimating covariate-adjusted measures of diagnostic accuracy based on pooled biomarker assessments. Biom J. 2016 Jul; 58(4):944-61.
    View in: PubMed
    Score: 0.005
  43. A flexible, computationally efficient method for fitting the proportional hazards model to interval-censored data. Biometrics. 2016 Mar; 72(1):222-31.
    View in: PubMed
    Score: 0.005
  44. A general regression framework for group testing data, which incorporates pool dilution effects. Stat Med. 2015 Nov 30; 34(27):3606-21.
    View in: PubMed
    Score: 0.005
  45. Two-stage hierarchical group testing for multiple infections with application to the infertility prevention project. Biometrics. 2013 Dec; 69(4):1064-73.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.